We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVNT icon
2026
Avient
AVNT
$3.45B
$1K ﹤0.01%
50
– –
EFC
2027
Ellington Financial
EFC
$1.68B
$1K ﹤0.01%
64
– –
EGAN icon
2028
eGain
EGAN
$176M
$1K ﹤0.01%
165
-15
-8% -$136
EME icon
2029
Emcor
EME
$33.1B
$1K ﹤0.01%
25
– –
EWX icon
2030
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$662M
$1K ﹤0.01%
35
– –
FARM
2031
DELISTED
Farmer Brothers
FARM
$1K ﹤0.01%
100
– –
FRBA icon
2032
First Bank
FRBA
$451M
$1K ﹤0.01%
+300
New +$1.9K
GLAD icon
2033
Gladstone Capital
GLAD
$425M
$1K ﹤0.01%
101
– –
HEI icon
2034
HEICO Corp
HEI
$48.9B
$1K ﹤0.01%
44
– –
NVAX icon
2035
Novavax
NVAX
$1.23B
$1K ﹤0.01%
15
-4,082
-100% -$456K
NVMI
2036
Nova
NVMI
$13.9B
$1K ﹤0.01%
100
– –
OCSL icon
2037
Oaktree Specialty Lending
OCSL
$1.03B
$1K ﹤0.01%
51
– –
PNNT
2038
Pennant Park Investment Corp
PNNT
$215M
$1K ﹤0.01%
131
– –
BCIC
2039
BCP Investment Corp
BCIC
$86.9M
$1K ﹤0.01%
19
– –
RGT
2040
Royce Global Value Trust
RGT
$95.8M
$1K ﹤0.01%
+131
New +$1.14K
STAA icon
2041
STAAR Surgical
STAA
$1.16B
$1K ﹤0.01%
+100
New +$1.61K
TRNO icon
2042
Terreno Realty
TRNO
$7.68B
$1K ﹤0.01%
68
-7
-9% -$126
IMGN
2043
DELISTED
Immunogen Inc
IMGN
$1K ﹤0.01%
130
-617
-83% -$9.73K
NNA
2044
DELISTED
Navios Maritime Acquisition Corporation
NNA
$1K ﹤0.01%
33
– –
CLCT
2045
DELISTED
Collectors Universe
CLCT
$1K ﹤0.01%
98
– –
NFX
2046
DELISTED
Newfield Exploration
NFX
$1K ﹤0.01%
37
– –
ADRE
2047
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$1K ﹤0.01%
50
– –
WHX
2048
DELISTED
WHITING USA TRUST I UNITS OF BENE INT
WHX
$1K ﹤0.01%
650
– –
KOG
2049
DELISTED
KODIAK OIL & GAS CORP
KOG
$1K ﹤0.01%
100
– –
KFN
2050
DELISTED
KKR FINANCIAL HOLDINGS LLC COM
KFN
$1K ﹤0.01%
165
– –
80 81
82
83 84

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.